Emerging Growth Research Updates SBC Medical Group Rating
Emerging Growth Research has released its Q2:26 quarterly update on SBC Medical Group, reiterating a buy rating and increasing the price target to $11.00.
2 stories found
Emerging Growth Research has released its Q2:26 quarterly update on SBC Medical Group, reiterating a buy rating and increasing the price target to $11.00.
Several financial institutions, including UBS, H.C. Wainwright, and Stifel, have adjusted their stock ratings and price targets for various companies. These changes reflect updated outlooks on growth, dilution concerns, and market conditions.